|
Volumn 96, Issue 6, 2005, Pages 909-910
|
Light at the end of the tunnel for interstitial cystitis?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALOSETRON;
ANALGESIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
ANTIINFLAMMATORY AGENT;
BCG VACCINE;
BIOXELL;
BXL 628;
COLECALCIFEROL DERIVATIVE;
DARIFENACIN;
DIMETHYL SULFOXIDE;
HEPARIN;
MUSCARINIC RECEPTOR BLOCKING AGENT;
OXYBUTYNIN;
PENTOSAN POLYSULFATE;
SEROTONIN AGONIST;
TOLTERODINE;
UNCLASSIFIED DRUG;
ACUPUNCTURE;
BEHAVIOR MODIFICATION;
BLADDER PRESSURE;
CLINICAL FEATURE;
CLINICAL TRIAL;
DIETARY INTAKE;
DISEASE EXACERBATION;
HUMAN;
IMPAIRED BLADDER EMPTYING;
INTERSTITIAL CYSTITIS;
PAIN;
PATHOPHYSIOLOGY;
PELVIS PAIN SYNDROME;
PREVALENCE;
PRIORITY JOURNAL;
REVIEW;
SYMPTOM;
TRANSCUTANEOUS NERVE STIMULATION;
URINARY FREQUENCY;
URINARY URGENCY;
CYSTITIS, INTERSTITIAL;
HUMANS;
|
EID: 25844453952
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1464-410X.2005.05840.x Document Type: Review |
Times cited : (4)
|
References (1)
|